JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 126 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $66,000 | -29.0% | 28,212 | -8.0% | 0.00% | 0.0% |
| Q2 2022 | $93,000 | -74.2% | 30,656 | -42.3% | 0.00% | -75.0% |
| Q1 2022 | $361,000 | -27.1% | 53,124 | -10.4% | 0.00% | -33.3% |
| Q4 2021 | $495,000 | +32.0% | 59,298 | +2.7% | 0.01% | +200.0% |
| Q3 2018 | $375,000 | +3.9% | 57,738 | +22.5% | 0.00% | 0.0% |
| Q2 2018 | $361,000 | -62.6% | 47,138 | +9.3% | 0.00% | -75.0% |
| Q1 2018 | $964,000 | +112.3% | 43,139 | +21.0% | 0.01% | +166.7% |
| Q4 2017 | $454,000 | -8.1% | 35,642 | +12.5% | 0.00% | -25.0% |
| Q3 2017 | $494,000 | +21.4% | 31,676 | +9.1% | 0.00% | +33.3% |
| Q2 2017 | $407,000 | – | 29,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |